Market revenue in 2023 | USD 1,085.9 million |
Market revenue in 2030 | USD 1,810.6 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Vitamins |
Fastest growing segment | Glucosamine |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Vitamins, Minerals, Collagen, Omega-3, Glucosamine |
Key market players worldwide | Herbalife Ltd, GNC, The Bountiful Company, Amway Malaysia Holdings, Basf SE, Bayer AG, Glanbia PLC, NOW Foods |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bone and joint health supplements market will help companies and investors design strategic landscapes.
Vitamins was the largest segment with a revenue share of 30.77% in 2023. Horizon Databook has segmented the U.S. bone and joint health supplements market based on vitamins, minerals, collagen, omega-3, glucosamine covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. population, especially in the age group of 19 to 50 years, is increasingly becoming health-conscious owing to the growing incidence of chronic bone conditions such as arthritis, osteoporosis, and others, which is also one of the significant factors boosting adoption of health supplements in the country. High prevalence of multi nutrient deficiency among people of different age groups is further boosting the demand for these health supplements in the country.
According to a CDC report, at present, about 1 in 4 adults (23.7%), or 58.5 million people, is suffering from arthritis in the country. However, a higher percentage of women, i.e., 23.5% suffer from arthritis, whereas only 18.1% men suffer from the condition. The penetration rate of doctor-diagnosed arthritis is projected to reach 78.4 million, out of which about 34.6 million are expected to report an arthritis-attributable activity limitation.
Growing awareness about benefits related to such supplements is expected to further boost market growth over the forecast period. According to a consumer survey conducted by the Council for Responsible Nutrition (CRN) in 2017, 76% of adults in the U.S., comprising 56% women consumers, took dietary supplements. In addition, the usage of supplements among the Americans has steadily increased over the past 20 years, and as of 2021, 80% of the Americans were consuming dietary supplements.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. bone and joint health supplements market, including forecasts for subscribers. This country databook contains high-level insights into U.S. bone and joint health supplements market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account